Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children

Chris P Verschoor; Pardeep Singh; Margaret L Russell; Dawn M E Bowdish; Angela Brewer; Louis Cyr; Brian J Ward; Mark Loeb

doi:10.1371/journal.pone.0131531

Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children

PLoS One. 2015 Jun 24;10(6):e0131531. doi: 10.1371/journal.pone.0131531. eCollection 2015.

Authors

Chris P Verschoor¹, Pardeep Singh², Margaret L Russell³, Dawn M E Bowdish¹, Angela Brewer⁴, Louis Cyr⁴, Brian J Ward⁴, Mark Loeb⁵

Affiliations

¹ McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Michael G DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
² Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
³ Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
⁴ Research Institute of the McGill University Health Center, Montreal, QC, Canada.
⁵ McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; Michael G DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.

Abstract

Although the microneutralization (MN) assay has been shown to be more sensitive than the hemagglutination inhibition (HAI) assay for the measurement of humoral immunity against influenza viruses, further evidence relating MN titres to protective efficacy against infection is needed. Serum antibodies against seasonal H1N1 and H3N2 influenza were measured in children and adolescents (n = 656) by MN and hemagglutination inhibition (HAI) assays. Compared to HAI, the MN assay is more sensitive in detecting serum antibodies and estimates of protective effectiveness against PCR-confirmed infection were higher for both subtypes. Given our findings, the MN assay warrants further consideration as a formal tool for the routine evaluation of vaccine-induced antibody responses.

Publication types

Randomized Controlled Trial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Alberta
Antibodies, Viral / blood*
Antibody Formation / immunology
Child
Child, Preschool
Hemagglutination Inhibition Tests
Hemagglutinin Glycoproteins, Influenza Virus / immunology
Humans
Immunity, Humoral / immunology
Influenza A Virus, H1N1 Subtype*
Influenza A Virus, H3N2 Subtype*
Influenza Vaccines
Influenza, Human / immunology*
Manitoba
Neutralization Tests
Polymerase Chain Reaction
Prospective Studies

Substances

Antibodies, Viral
Hemagglutinin Glycoproteins, Influenza Virus
Influenza Vaccines
hemagglutinin, human influenza A virus

Abstract

Publication types

MeSH terms

Substances

Grants and funding